D-Pharm Overview
- Year Founded
-
1993
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
D-Pharm General Information
Description
Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.
Contact Information
Website
www.dpharm.comCorporate Office
- Kiryat Weizmann Science Park
- Building 7
- Rehovot 76123
- Israel
Corporate Office
- Kiryat Weizmann Science Park
- Building 7
- Rehovot 76123
- Israel
D-Pharm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 28-Mar-2018 | Completed | Generating Revenue | |||
| 7. PIPE | 22-Jan-2015 | Completed | Generating Revenue | |||
| 6. IPO | 17-Aug-2009 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 07-Jul-2009 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 14-May-2006 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series AA) | 30-Sep-2001 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 03-Apr-1997 | $6M | $8M | Completed | Startup | |
| 1. Early Stage VC | 01-Jan-1995 | $2M | $2M | Completed | Startup |
D-Pharm Patents
D-Pharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015092788-A1 | Compositions comprising lipophilic diesters of chelating agents non-covalently associated with organic amines | Inactive | 17-Dec-2013 | ||
| WO-2015092789-A1 | Onium salts of lipophilic diesters of chelating agents | Inactive | 17-Dec-2013 | ||
| WO-2011086561-A1 | Process for the preparation of 3-(1-cyclopropenyl) propionic acid and its salts | Inactive | 17-Jan-2010 | ||
| AU-2008278568-A1 | Peptides derived from plasminogen activator inhibitor-1 and uses thereof | Active | 24-Jul-2007 | ||
| AU-2008278568-B2 | Peptides derived from plasminogen activator inhibitor-1 and uses thereof | Inactive | 24-Jul-2007 | C07K14/8132 |
D-Pharm Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apax Partners | PE/Buyout | Minority | ||
| Care Capital | Venture Capital | Minority | ||
| Clal Biotechnology Industries | Venture Capital | Minority | ||
| Denali Ventures | Venture Capital | Minority | ||
| Gemini Israel Ventures | Venture Capital | Minority |
D-Pharm Acquisitions (1)
D-Pharm’s most recent deal was a Merger/Acquisition with Thrombotech. The deal was made on 24-Jul-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Thrombotech | 24-Jul-2012 | Merger/Acquisition | Drug Discovery |
D-Pharm Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Thrombotech | Ness Ziona, Israel | 2000 |
D-Pharm FAQs
-
When was D-Pharm founded?
D-Pharm was founded in 1993.
-
Where is D-Pharm headquartered?
D-Pharm is headquartered in Rehovot, Israel.
-
What industry is D-Pharm in?
D-Pharm’s primary industry is Therapeutic Devices.
-
Is D-Pharm a private or public company?
D-Pharm is a Private company.
-
What is D-Pharm’s current revenue?
The current revenue for D-Pharm is .
-
How much funding has D-Pharm raised over time?
D-Pharm has raised $71.7M.
-
Who are D-Pharm’s investors?
Apax Partners, Care Capital, Clal Biotechnology Industries, Denali Ventures, and Gemini Israel Ventures are 5 of 16 investors who have invested in D-Pharm.
-
When was D-Pharm acquired?
D-Pharm was acquired on 28-Mar-2018.
-
Who acquired D-Pharm?
D-Pharm was acquired by UNV Medicine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process